9) Background. Severe left ventricular (LV) hypertroph ncreases risk for adverse outcome after aortic va eplacement. Whether LV geometry influences mortali isk after aortic valve replacement is unclear. A hether LV mass or relative wall thickness (RWT) be redicts risk for adverse postoperative outcomes is nown. The purpose of this investigation was to exam he influence of LV geometry and LV hyp...

BACKGROUND Left ventricular (LV) hypertrophy caused by aortic valve stenosis (AS) leads to cardiovascular morbidity and mortality. We sought to determine whether aortic valve replacement (AVR) decreases LV mass and improves LV function. MATERIALS AND METHODS Retrospective review for 358 consecutive patients, who underwent aortic valve replacement for degenerative AS between January 1995 and D...

Normotensive and hypertensive subjects with and without left ventricular (LV) hypertrophy (LV mass index [LVMI] >51 g/m(2.7)) were examined by conventional echocardiography and tissue Doppler imaging of mitral annulus motion. The subgroups included nonobese normotensive subjects (n=16; age 51+/-9 years; 11 female; systolic blood pressure [SBP] 109+/-11 mm Hg, body mass index [BMI] 24+/-2.7 kg/m...

Left ventricular (LV) trabeculation has been studied in certain forms of cardiomyopathy. However, the changes of LV endocardial trabeculation during the remodeling process leading to heart failure (HF) are unclear. Seventy-four patients with systolic heart failure (SHF), 65 with heart failure with preserved ejection fraction (HFpEF) and 61 without HF were prospectively enrolled. All subjects re...

Purpose: The aim of this study was to determine left ventricular (LV) mass index via echocardiography in end-stage renal disease patients (ESRD) before and after renal transplantation, and its association with one-year survival. Materials and Methods: Forty-seven patients with ESRD who were candidate for renal transplantation were evaluated with echocardiography before and 4 months after the op...

BACKGROUND Echocardiographically determined left ventricular (LV) mass predicts adverse cardiovascular events in the general population. We have assessed the correlates of LV mass in a population-based study focusing on lifestyle and salt intake. METHODS AND RESULTS A random sample of 120 persons born in 1954 was invited; 93 (42 men) entered the study. The subjects' physical activity and alco...

Objectives We BLOCKINused BLOCKINserial BLOCKINcardiovascular BLOCKINmagnetic BLOCKINresonance BLOCKINimaging BLOCKIN(CMR) BLOCKINin BLOCKINmutation BLOCKINcarriers to monitor LV mass, LV function, LV morphology and left atrial (LA) volumes to gain insight BLOCKINin BLOCKINthe BLOCKINnatural BLOCKINcourse BLOCKINof BLOCKINdevelopment BLOCKINof BLOCKINHCM.

BACKGROUND A biomarker that is of great interest in relation to adverse cardiovascular events is soluble ST2 (sST2), a member of the interleukin family. Considering that metabolic syndrome (MetS) is accompanied by a proinflammatory state, we aimed to assess the relationship between sST2 and left ventricular (LV) structure and function in patients with MetS. METHODS A multicentric, cross-secti...

AIMS The extent to which left ventricular (LV) mass, an independent cardiovascular risk factor, is determined by genetic factors is unclear. The aim of this study was to assess the heritability of LV mass and its association with three potential candidate genes. METHODS A population-based adult twin study model was utilized. Echocardiographic assessment of LV mass was performed in 110 twin pa...

OBJECTIVES The goal of this study was to assess the relations of electrocardiographic QRS duration to left ventricular (LV) measurements in individuals without heart failure (HF) or prior myocardial infarction (MI). BACKGROUND Increased electrocardiographic QRS duration (>/=120 ms) is a marker of ventricular dyssynchrony. METHODS We evaluated the relations of maximal electrocardiographic QR...